Innovative Research Award
Bart Meuris
University Hospitals Leuven, Belgium
| Bart Meuris |
| Affiliation |
University Hospitals Leuven |
| Country |
Belgium |
| Scopus ID |
6602378855 |
| Documents |
208 |
| Citations |
7,574 |
| h-index |
37 |
| Subject Area |
Cardiac Devices and Implants |
| Event |
International Research Awards on Cardiology & Cardiovascular Medicine |
| ORCID |
0000-0001-9176-293X |
Bart Meuris is a Belgian cardiovascular researcher, cardiac surgeon, and academic leader associated with University Hospitals Leuven and the Department of Cardiovascular Sciences. His scholarly work focuses on cardiac surgery, heart valve technologies, transcatheter interventions, cardiovascular biomaterials, and mechanical circulatory support systems. Through an extensive publication portfolio and sustained contributions to cardiovascular innovation, Meuris has played a significant role in advancing clinical and translational research within the field of cardiac devices and implants.[1]
Abstract
Bart Meuris has established a distinguished academic record in cardiovascular medicine through research addressing heart valve replacement, transcatheter therapies, surgical innovation, thrombosis prevention, and device performance evaluation. His work integrates engineering principles with clinical practice to improve patient outcomes in structural heart disease. With more than two hundred indexed publications and thousands of citations, his research demonstrates substantial influence within contemporary cardiovascular science.[1]
Keywords
Cardiac Surgery, Heart Valve Replacement, Transcatheter Aortic Valve Implantation, Cardiovascular Devices, Valve Durability, Mechanical Valve Thrombosis, Cardiovascular Innovation, Structural Heart Disease.
Introduction
The development of safer and more durable cardiovascular devices remains a major priority in modern medicine. Bart Meuris has contributed to this objective through investigations of surgical and transcatheter valve technologies, device-related complications, and long-term cardiovascular outcomes. His work reflects a multidisciplinary approach that combines clinical evidence, biomedical engineering, and translational research to address complex cardiovascular challenges.[2]
Research Profile
As Chair within the Department of Cardiovascular Sciences at Universitair Ziekenhuis Leuven, Meuris has maintained active involvement in research concerning prosthetic heart valves, cardiovascular surgery, hemodynamics, and implant performance assessment. His scholarly output spans clinical studies, registry analyses, experimental investigations, and collaborative international projects. The breadth of his publication record reflects sustained engagement with emerging cardiovascular technologies and evidence-based treatment strategies.[3]
Research Contributions
- Investigated Factor XI inhibition strategies for preventing mechanical valve thrombosis in experimental models.[4]
- Evaluated sex-related outcomes following sutureless aortic valve replacement using registry-based evidence.[5]
- Examined the current status and future development of rapid deployment valve technologies.[6]
- Studied durability and hemodynamic performance of transcatheter valves used in aortic stenosis treatment.[7]
Publications
Recent publications authored or co-authored by Meuris include studies on Factor XI inhibition for mechanical valve thrombosis prevention, sex-related outcomes following Perceval Plus valve replacement, rapid deployment valve technologies, transcatheter valve durability, and cerebrovascular complications following transcatheter aortic valve implantation. These works collectively address clinical efficacy, procedural safety, and long-term device performance.[4][7]
Research Impact
The measurable influence of Meuris’s research is reflected by an h-index of 37, more than 7,500 citations, and a substantial body of peer-reviewed publications. His investigations have contributed to understanding cardiovascular device performance, surgical outcomes, and thrombosis prevention strategies, supporting evidence-based advancements in cardiovascular medicine and cardiac surgery.[1]
Award Suitability
Bart Meuris demonstrates qualifications aligned with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine. His sustained publication record, leadership within cardiovascular sciences, and contributions to cardiac device innovation illustrate a commitment to advancing clinical research and improving cardiovascular healthcare delivery. The scope and impact of his work support consideration for recognition under the Innovative Research Award category.
Conclusion
Through extensive research in heart valve technologies, cardiovascular implants, and surgical innovation, Bart Meuris has contributed meaningful knowledge to the field of cardiovascular medicine. His combination of academic leadership, scientific productivity, and translational research impact positions him as a notable contributor to contemporary cardiac science and device development.
External Links
References
- Elsevier. (n.d.). Scopus author details: Bart Meuris, Author ID 6602378855. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=6602378855
- ORCID. (n.d.). Bart Meuris Research Profile.
https://orcid.org/0000-0001-9176-293X
- Universitair Ziekenhuis Leuven. (2024). Department of Cardiovascular Sciences Employment Record.
- Meuris, B. et al. (2026). Factor XI inhibition with gruticibart prevents mechanical valve thrombosis in a porcine pulmonary model.
DOI: https://doi.org/10.1016/j.bvth.2026.100168
- Meuris, B. et al. (2026). Sex-related outcome after sutureless aortic valve replacement with Perceval Plus.
DOI: https://doi.org/10.1093/icvts/ivag170
- Meuris, B. et al. (2026). Rapid deployment valves: current position on the market and future directions.
DOI: https://doi.org/10.1080/17434440.2026.2638363
- Meuris, B. et al. (2026). Hemodynamic performance and durability of transcatheter valves for native aortic valve stenosis.
DOI: https://doi.org/10.1080/00015385.2025.2576449